Sybille Mazurek

4.1k total citations · 2 hit papers
45 papers, 3.4k citations indexed

About

Sybille Mazurek is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Sybille Mazurek has authored 45 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Cancer Research and 9 papers in Physiology. Recurrent topics in Sybille Mazurek's work include Cancer, Hypoxia, and Metabolism (23 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer-related Molecular Pathways (5 papers). Sybille Mazurek is often cited by papers focused on Cancer, Hypoxia, and Metabolism (23 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer-related Molecular Pathways (5 papers). Sybille Mazurek collaborates with scholars based in Germany, Austria and India. Sybille Mazurek's co-authors include E. Eigenbrodt, Werner Zwerschke, F Hugo, C. B. Boschek, Pidder Jansen‐Dürr, R. Bamezai, Mohammad Askandar Iqbal, Gopinath Prakasam, Eveline Hütter and Lawrence Banks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Sybille Mazurek

44 papers receiving 3.3k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pyruvate kinase type M2 and its role in tumor growth and spreading

2005 670 citations Sybille Mazurek, C. B. Boschek et al. Seminars in Cancer Biology profile →
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells

2010 554 citations Sybille Mazurek The International Journal of Biochemistry & Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sybille Mazurek Germany	24	2.3k	1.8k	537	346	330	45	3.4k
Jason R. Cantor United States	19	2.5k 1.1×	1.2k 0.7×	467 0.9×	329 1.0×	299 0.9×	27	3.6k
Tzuling Cheng United States	10	3.1k 1.3×	1.9k 1.0×	603 1.1×	426 1.2×	526 1.6×	15	4.3k
Sucheta Telang United States	27	1.8k 0.8×	1.5k 0.8×	613 1.1×	162 0.5×	241 0.7×	52	2.9k
George Simos Greece	44	4.1k 1.8×	1.5k 0.8×	488 0.9×	314 0.9×	303 0.9×	98	5.3k
Gary R. Pasternack United States	29	2.5k 1.1×	1.7k 0.9×	597 1.1×	409 1.2×	148 0.4×	57	3.8k
Dimitris Athineos United Kingdom	26	2.6k 1.1×	996 0.5×	1.2k 2.3×	192 0.6×	235 0.7×	36	3.7k
Mei Kong United States	25	2.2k 0.9×	1.2k 0.7×	558 1.0×	199 0.6×	1.1k 3.2×	42	3.4k
David F. Kashatus United States	26	2.2k 0.9×	777 0.4×	381 0.7×	313 0.9×	357 1.1×	41	2.9k
Ju‐Gyeong Kang United States	19	2.2k 1.0×	1.0k 0.5×	626 1.2×	305 0.9×	206 0.6×	36	3.1k
Pasquale Chieco Italy	33	2.6k 1.1×	1.6k 0.9×	1.4k 2.6×	193 0.6×	384 1.2×	108	4.5k

Countries citing papers authored by Sybille Mazurek

Since Specialization

Citations

This map shows the geographic impact of Sybille Mazurek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sybille Mazurek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sybille Mazurek more than expected).

Fields of papers citing papers by Sybille Mazurek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sybille Mazurek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sybille Mazurek. The network helps show where Sybille Mazurek may publish in the future.

Co-authorship network of co-authors of Sybille Mazurek

This figure shows the co-authorship network connecting the top 25 collaborators of Sybille Mazurek. A scholar is included among the top collaborators of Sybille Mazurek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sybille Mazurek. Sybille Mazurek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hanke, Dennis, et al.. (2025). In Vitro Inhibition of Cryptosporidium parvum Infection by the Olive Oil Component Oleocanthal. Pathogens. 14(10). 1002–1002. 1 indexed citations

Nikitopoulou, Efterpi, Natascha Sommer, Thomas Linn, et al.. (2025). Impact of mtG3PDH inhibitors on proliferation and metabolism of androgen receptor-negative prostate cancer cells: Role of extracellular pyruvate. PLoS ONE. 20(6). e0325509–e0325509. 2 indexed citations

Dolga, Amalia M., Birgit Honrath, Sybille Mazurek, et al.. (2022). SK-Channel Activation Alters Peripheral Metabolic Pathways in Mice, but Not Lipopolysaccharide-Induced Fever or Inflammation. SHILAP Revista de lepidopterología. 3 indexed citations

Mazurek, Sybille, et al.. (2020). Mesenchymal stem cells promote pancreatic β-cell regeneration through downregulation of FoxO1 pathway. Stem Cell Research & Therapy. 11(1). 497–497. 27 indexed citations

Glenske, Kristina, et al.. (2020). Effect of long term palmitate treatment on osteogenic differentiation of human mesenchymal stromal cells - Impact of albumin. Bone Reports. 13. 100707–100707. 5 indexed citations

Kruppke, Benjamin, Marcus Rohnke, Christiane Heinemann, et al.. (2019). Biomaterial based treatment of osteoclastic/osteoblastic cell imbalance – Gelatin-modified calcium/strontium phosphates. Materials Science and Engineering C. 104. 109933–109933. 19 indexed citations

Matés, José M., et al.. (2019). Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer. Seminars in Cell and Developmental Biology. 98. 34–43. 124 indexed citations

Helmig, Simone, et al.. (2017). Impact of biopersistent fibrous dusts on glycolysis, glutaminolysis and serine metabolism in A549 cells. Molecular Medicine Reports. 16(6). 9233–9241. 3 indexed citations

Glenske, Kristina, Daniela Fietz, Sybille Mazurek, et al.. (2016). Osteogenic differentiation capacity of human mesenchymal stromal cells in response to extracellular calcium with special regard to connexin 43. Annals of Anatomy - Anatomischer Anzeiger. 209. 18–24. 32 indexed citations

10.

Mazurek, Sybille & Maria C. Shoshan. (2015). Tumor Cell Metabolism. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 12 indexed citations

11.

Iqbal, Mohammad Askandar, Vibhor Gupta, Gopinath Prakasam, Sybille Mazurek, & R. Bamezai. (2014). Pyruvate kinase M2 and cancer: an updated assessment. FEBS Letters. 588(16). 2685–2692. 154 indexed citations

12.

Gupta, Vibhor, Gopinath Prakasam, Mohammad Askandar Iqbal, et al.. (2014). Interplay between Epigenetics & Cancer Metabolism. Current Pharmaceutical Design. 20(11). 1706–1714. 14 indexed citations

13.

Dhar, Dipok Kumar, Steven W.M. Olde Damink, Andrew Godfrey, et al.. (2012). Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer. Cancer. 119(3). 575–585. 34 indexed citations

14.

Mazurek, Sybille. (2010). Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells. The International Journal of Biochemistry & Cell Biology. 43(7). 969–980. 554 indexed citations breakdown →

15.

Kumar, Yogesh, Sybille Mazurek, Shiyu Yang, et al.. (2010). In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines. Tumor Biology. 31(2). 69–77. 14 indexed citations

16.

Spoden, Gilles A., Sybille Mazurek, Nicole Bacher, et al.. (2008). Isotype‐specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation. International Journal of Cancer. 123(2). 312–321. 72 indexed citations

17.

Mazurek, Sybille, C. B. Boschek, F Hugo, & E. Eigenbrodt. (2005). Pyruvate kinase type M2 and its role in tumor growth and spreading. Seminars in Cancer Biology. 15(4). 300–308. 670 indexed citations breakdown →

18.

García-Gonzalo, Francesc R., Cristina Cruz, Purificacı́on Muñoz, et al.. (2003). Interaction between HERC1 and M2‐type pyruvate kinase. FEBS Letters. 539(1-3). 78–84. 33 indexed citations

19.

Mazurek, Sybille, Werner Zwerschke, Pidder Jansen‐Dürr, & E. Eigenbrodt. (2001). Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex. Biochemical Journal. 356(1). 247–247. 116 indexed citations

20.

Hugo, F, et al.. (1992). In vitro effect of extracellular AMP on MCF‐7 breast cancer cells: Inhibition of glycolysis and cell proliferation. Journal of Cellular Physiology. 153(3). 539–549. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact